Dr. Cacabelos is a pioneer in Pharmaco-Epigenetics, a discipline that studies the interaction between genes and medicines, allowing the doctor to find the most appropriate treatment
Dr. Ramón Cacabelos was born in Cambados -Galicia-, graduated in Medicine and Surgery from the University of Oviedo, obtained a Doctorate in Medicine and Surgery from the University of Santiago de Compostela. After his training in Spain he reinforced his career spending a decade in Japan getting a PhD in Medical Sciences, Internal Medicine and Psychiatry, and specializing in Psychiatry at the Faculty of Medicine of the University of Osaka.
He is also Professor of Genomic Medicine and president of the EuroEspes Group, an entity composed of different areas (medicine, biotechnology and scientific dissemination) based in La Coruña, Spain. ??Genomic Medicine area is headed by Dr. Ramón Cacabelos. His team provide assistance services, biomedical research, development of biopharmaceutical products, genomic diagnosis, personalized pharmacological treatments and scientific consulting to national and foreign centers.
In addition to the important contributions of the Genomics and Pharmacogenomics department, another of the Group's pioneering activities is Medical Epigenetics, through which inheritable and reversible changes are studied in genetic function without modifying the DNA sequence. In this way, epigenetics allows to deepen on neurodegenerative diseases (Alzheimer's disease, Parkinson's disease, multiple sclerosis), cardiovascular pathology, stroke or cancer. Epigenetic regulation is also related to the mechanism of action, transport, efficacy and resistance to specific medications.
Dr. Cacabelos has been a professor in the Department of Psychiatry of the Faculty of Medicine of the University of Santiago de Compostela, Professor of Human Physiology at the Complutense University of Madrid and Professor of Genomic Medicine at the Camilo José Cela University of Madrid, where He has also been Vice Rector of Research and Science.
He is considered one of the highest international Spanish scientists in diseases of the central nervous system, aging and dementia, and a pioneer in Genomic Medicine and PharmacoGenomics. He also holds the Presidency of the Spanish Society of Genomic Medicine and the World Association of Genomic Medicine.
He has currently published more than 1,500 international scientific articles, more than 20 books and he is editor in chief of the first World Guide for Grug Use and PharmacoGenomics.
Doctor Ramón Cacabelos extensive experience positions him in more than 50 global scientific committees for the evaluation of projects. He owns 10 formula patents that he has invented himself. The last two, the "EB-101" vaccine for Alzheimer's disease, registered at the US Patent Office; and "Atremorine", a bioproduct registered with the European Patent Office for the prevention and treatment of Parkinson's disease.
